News
Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mNEXSPIKE® (mRNA-1283),
CDC adjusts COVID vaccine guidance, but keeps on child schedule
The Centers for Disease Control and Prevention has issued updated advice on the COVID-19 vaccine days after Health and Human Services Secretary Robert F. Kennedy Jr said the agency would no longer recommend the shot to children and pregnant women.
The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...
The US Centers for Disease Control and Prevention has updated its immunization schedule for children after US Health and ...
The Centers for Disease Control and Prevention says children without underlying health conditions "may receive" a COVID-19 ...
The U.S. Centers for Disease Control and Prevention is still recommending COVID-19 vaccines for healthy children, according ...
While RFK Jr. said the coronavirus vaccine would be removed from the CDC schedule for healthy children, it’s still ...
Health Secretary Robert F. Kennedy Jr. recently announced more key changes to the CDC recommendations for COVID-19 ...
The Centers for Disease Control and Prevention now says that kids with no underlying health conditions "may receive" COVID-19 ...
A new, highly transmissible COVID subvariant has been detected in California — heightening the risk of a summer wave as ...
The US Department of Health and Human Services, under Secretary Robert F. Kennedy Jr., has recently made significant changes ...
Dr. Marty Makary, head of the U.S. Food and Drug Administration (FDA), said Wednesday that the decision should be made ...
The Trump administration's COVID-19 vaccine policy changes mean anyone who is healthy and under 65 will likely have to pay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback